Financials in USD. Standardized financial statements.
A compact view of how AC Immune S.A. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $3.57M | $27.31M | $14.80M | $3.94M | $0 | $15.43M | $110.46M | $7.19M | $20.25M | $23.21M |
| Revenue Growth? | -86.9% | +84.5% | +276.1% | 0.0% | -100.0% | -86.0% | +1435.4% | -64.5% | -12.7% | 0.0% |
| Cost of Revenue? | $0 | $62.57M | $54.61M | $0 | $0 | $59.49M | $50.43M | $44.28M | $32.66M | $25.77M |
| Gross Profit? | $3.57M | -$35.26M | -$39.80M | $3.94M | $0 | -$44.06M | $60.02M | -$37.08M | -$12.41M | -$2.56M |
| Gross Margin? | +100.0% | -129.1% | -268.9% | +100.0% | 0.0% | -285.5% | +54.3% | -515.5% | -61.3% | -11.0% |
| Operating Expenses? | $72.44M | $17.12M | $13.82M | $74.78M | $79.01M | $17.20M | $15.49M | $56.74M | $42.79M | $33.67M |
| Operating Income? | -$68.86M | -$52.38M | -$53.62M | -$70.85M | -$79.01M | -$61.26M | $44.54M | -$49.55M | -$22.54M | -$10.46M |
| EBITDA? | -$67.75M | -$48.62M | -$51.83M | -$68.03M | -$70.01M | -$59.73M | $45.81M | -$49.66M | -$22.54M | -$6.81M |
| Income Before Tax | -$70.45M | -$50.91M | -$54.22M | -$70.74M | -$72.99M | -$61.92M | $45.44M | -$50.95M | -$26.41M | -$7.10M |
| Income Tax Expense | $0 | $3,000 | $10,000 | $13,000 | $3,000 | $0 | $0 | $0 | $147,000 | $0 |
| Net Income? | -$70.45M | -$50.92M | -$54.23M | -$70.75M | -$73.00M | -$61.92M | $45.44M | -$50.95M | -$26.41M | -$7.10M |
| EPS? | $-0.70 | $-0.51 | $-0.64 | $-0.85 | $-0.97 | $-0.86 | $0.64 | $-0.82 | $-0.46 | $-0.14 |
| Diluted EPS? | $-0.70 | $-0.51 | $-0.64 | $-0.85 | $-0.97 | $-0.86 | $0.64 | $-0.82 | $-0.46 | $-0.14 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality